ligands acting on targets

17-phenyl trinor PGF2α isopropyl ester is the isopropyl ester of the free acid prostaglandin which corresponds to bimatoprost. This free acid, 17-phenyl trinor PGF2α, is a potent FP receptor agonist. In human and animal models of glaucoma, FP

17-phenyl trinor Prostaglandin A2 (PGA2) is a synthetic prostaglandin analog designed for greater potency and increased half-life relative to PGA2. There are no published reports of the biological activity of 17-phenyl trinor PGA2 in the literature

17-phenyl trinor Prostaglandin A2 (PGA2) is a synthetic prostaglandin analog designed for greater potency and increased half-life relative to PGA2. There are no published reports of the biological activity of 17-phenyl trinor PGA2 in the literature

17-phenyl trinor Prostaglandin D2 (17-phenyl trinor PGD2) is a novel, chemically stable analog of PGD2 wherein the lower side chain is modified by the addition of a phenyl group at C-17 in place of the last 3 ω-chain carbon atoms. This modification

17-phenyl trinor Prostaglandin D2 (17-phenyl trinor PGD2) is a novel, chemically stable analog of PGD2 wherein the lower side chain is modified by the addition of a phenyl group at C-17 in place of the last 3 ω-chain carbon atoms. This modification

17-phenyl trinor Prostaglandin E2 (17-phenyl trinor PGE2) is a synthetic analog of PGE2. It is an EP1 and EP3 receptor agonist.1,2 17-phenyl trinor PGE2 causes contraction of the guinea pig ileum at a concentration of 11 µM. It is slightly less

17-phenyl trinor Prostaglandin E2 (17-phenyl trinor PGE2) is a synthetic analog of PGE2. It is an EP1 and EP3 receptor agonist.1,2 17-phenyl trinor PGE2 causes contraction of the guinea pig ileum at a concentration of 11 µM. It is slightly less

17-phenyl trinor-13,14-dihydro Prostaglandin A|2|is a synthetic PG analog with biological activity not widely reported. The PGF2α analog latanoprost, bearing the same features as the lower side chain, has recently been approved as a pharmaceutical

17-phenyl trinor-13,14-dihydro Prostaglandin A|2|is a synthetic PG analog with biological activity not widely reported. The PGF2α analog latanoprost, bearing the same features as the lower side chain, has recently been approved as a pharmaceutical

17-phenyl-Ω-trinor-PGE₂.

17-phenyl-Ω-trinor-PGE₂.

17-trans PGE3 is an isomer of PGE3 which could result from COX metabolism of dietary trans-fatty acids. There are no published reports on the biological activity of this compound.